Study reported SGLT2 Inhibitors monotherapy might not lead to DKA events as opposed to insulin therapy.
Read More »SGLT-2 Part 3
In this week's Homerun Slides, understanding the need for cultural competence and the strategies to overcome cultural barriers.
Read More »Effectiveness of Invokamet in Drug-Naïve Type 2 Diabetes
Study answers question of just how effective is a SGLT-2 inhibitor with metformin.
Read More »SGLT-2 Part 2
In this week's Homerun Slides, the safety warnings, precautions, and incorporation of SGLT-2 inhibitors into diabetes treatment.
Read More »What Happens When You Have Two SGLT Inhibitors: SGLT-1 + SGLT-2 = ?
New dual drug could be a diabetes breakthrough.
Read More »Uncommon Side Effect of SGLT-2 Inhibitors
Even though amputation is not a major effect, it is still important to let patients know about it and how to prevent it with proper foot care.
Read More »SGLT-2 Part 1
In this week's Homerun Slides, talking to patients about SGLT-2 as a treatment option.
Read More »Caution: NSAIDs with SGLT-2 Inhibitors May Cause Renal Injuries
New research finds issue in the setting of dehydration and/or during use of nonsteroidal anti-inflammatory agents (NSAIDs) or radiocontrast studies.
Read More »Ertugliflozin Monotherapy in Patients with Type 2 Inadequately Controlled
Phase-3 study to evaluate efficacy and safety of ertugliflozin monotherapy.
Read More »EMPA-REG Outcome Trial, Part 7
In this week's Homerun Slides, the ratios of the adverse events in patients and their tolerability of the placebo vs empagliflozin.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.